Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic comparison of original versus generic extended-release tacrolimus in Thai kidney transplant recipients
TCTR20261007004Phase 2Completed
- Sponsor
- Lotus Pharmaceutical
- Start
- Aug 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus, sponsored by Lotus Pharmaceutical. Started Aug 2025; status: completed.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on TCTR20261007004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007004.